Tag: targeted therapy
-
Truqap Becomes the First Targeted Therapy for PTEN‑Deficient Metastatic Prostate Cancer
Prostate cancer remains one of the most common cancers affecting men worldwide, and while many cases respond well to early treatment, advanced forms of the disease can be far more difficult to manage. A major challenge has been finding effective therapies for aggressive subtypes that grow and spread quickly. One of these subtypes involves tumors…
-
FDA Approves Ziftomenib for Acute Myeloid Leukemia
The treatment landscape for acute myeloid leukemia (AML) has recently seen a significant development with the U.S. Food and Drug Administration (FDA) granting full approval to ziftomenib (Komzifti™) for adult patients diagnosed with relapsed or refractory (R/R) AML who harbor a susceptible NPM1 (Nucleophosmin 1) mutation and have no satisfactory alternative treatment options. This landmark…
-
Breakthrough Cancer Drug With No Detectable Side Effects
A significant nanomedicine breakthrough from Northwestern University, led by Prof. Chad A. Mirkin and documented in the peer-reviewed journal ACS Nano, details the transformation of the chemotherapy agent 5-fluorouracil (5-Fu) into a spherical nucleic acid (SNA) structure. According to both the article and surrounding scientific coverage, this innovation reports unprecedented increases in cancer cell targeting…